CASI Pharmaceuticals, Inc. Total Assets

Quick Answer

CASI Pharmaceuticals, Inc. reported Total Assets of $53.67 million for the year ending 2024.

  • CASI Pharmaceuticals, Inc. showed a decrease of -28.7% in Total Assets from 2023 to 2024.
  • This data is from CASI Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
  • XBRL data for this metric is available from 2021 to 2024 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2021 to 2024), CASI Pharmaceuticals, Inc.'s Total Assets has declined by 61.2%.
  • Historical annual values: Fiscal year 2024: $53.67 million | Fiscal year 2023: $75.27 million | Fiscal year 2022: $96.23 million | Fiscal year 2021: $138.30 million.
  • Data sourced from SEC EDGAR public filings as of August 4, 2026.

Last verified: